DiogenX

????We are pleased to introduce Dr. Klara Owen as DiogenX Chief Medical Officer! Dr. Owen brings a wealth of expertise in diabetes and metabolic disorders, backed by over a decade in senior leadership roles at top international pharma and biotech companies. Her experience covers areas ranging from rare pediatric diseases to Type 1 diabetes (T1D) treatment. “I am excited to begin my new role at DiogenX,”?Dr. Owen shared.?“The company’s preclinical achievements are truly remarkable, and I am honored to contribute my expertise in both clinical diabetes care and drug development. Being part of a company with a mission to prevent and reverse T1D—and improve quality of life for millions—is incredibly inspiring.” Learn more about Dr. Owen’s appointment and our vision for the future of diabetes treatment in the full press release below ?? #DiabetesCare #Leadership #T1D #Biotech #Innovation #CMO #DiogenX

?? We are thrilled to welcome Dr. Leni Ramos to our Board of Directors! As an independent board member, Dr Ramos brings a wealth of expertise to DiogenX including her instrumental involvement in the approval of teplizumab-mzwv, the first disease-modifying treatment for the delay of Stage 3 T1D. “I look forward to leveraging my expertise and experience in T1D to support the company in its vision following its successful Series A investment round. DiogenX has unveiled promising preclinical work and I am excited to be involved in the development of a therapy that has the potential to prevent and reverse T1D.” – Dr Leni Ramos Read the full press release?? https://lnkd.in/dCVTFVVV #diabetes #appointments #T1D #biotech?

DiogenX is hiring a full-time on-site (Marseille or Nice) experienced Bioanalytical Manager. Reporting to the Director, Drug Development Sciences, the Bioanalytical Manager will be responsible for overseeing the bioanalytical activities, including method development, sample analysis, and data interpretation. Interested? Know more:

DiogenX is hiring a full-time on-site (Marseille or Nice) experienced Bioanalytical Manager. Reporting to the Director, Drug Development Sciences, the Bioanalytical Manager will be responsible for overseeing the bioanalytical activities, including method development, sample analysis, and data interpretation. Interested? Know more:

DiogenX is pleased to announce the appointment of Helene Sicard as Chief Development Officer and the growth of its team as its lead candidate DGX-01 enters IND-enabling studies. Welcome Helene Sicard Laetitia Cohen Tannoudji Joanna Fares PhD Renaud Perret! Read the news: https://lnkd.in/dvrqpGCq #team #diabetes #T1D #diogenx #biotech #DGX-01